IGI, Laboratories, Inc. (IG)
-NYSE MKT 1.62 
0.05(2.99%) 4:00PM EDT
| Prev Close: | 1.67 |
|---|
| Open: | 1.65 |
|---|
| Bid: | 1.68 x 100 |
|---|
| Ask: | 2.10 x 100 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 0.84 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.62 - 1.71 |
|---|
| 52wk Range: | 0.94 - 2.25 |
|---|
| Volume: | 22,913 |
|---|
| Avg Vol (3m): | 59,427 |
|---|
| Market Cap: | 69.55M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.09 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- IGI LABORATORIES, INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- IGI Laboratories' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, Apr 25)
- IGI Laboratories Inc Earnings Call scheduled for 4:30 pm ET todayCCBN(Thu, Apr 25)
- IGI Laboratories Announces 1st Quarter 2013 ResultsBusiness Wire(Thu, Apr 25)
- IGI LABORATORIES, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhEDGAR Online(Thu, Apr 25)
- Q1 2013 IGI Laboratories Inc Earnings Release - Time Not SuppliedCCBN(Thu, Apr 25)
- IGI Laboratories to Hold Conference Call for 1st Quarter 2013 ResultsBusiness Wire(Thu, Apr 11)
- IGI Laboratories to Present at 12th Annual Needham & Company Annual Healthcare Conference on April 30, 2013Business Wire(Fri, Apr 5)
- IGI Laboratories announces 10th ANDA submissionat theflyonthewall.com(Thu, Apr 4)
- IGI Laboratories, Inc. Announces Tenth ANDA SubmissionBusiness Wire(Thu, Apr 4)
- IGI LABORATORIES, INC FinancialsEDGAR Online Financials(Wed, Apr 3)
- IGI LABORATORIES, INC Files SEC form 10-K, Annual ReportEDGAR Online(Thu, Mar 28)
- 3 Speculative Healthcare Companies With High Levels Of Insider Ownership - Part IIIat Seeking Alpha(Tue, Mar 26)
- IGI LABORATORIES, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Wed, Mar 20)
- 3 Speculative Healthcare Companies With High Levels Of Insider Ownership - Part IIat Seeking Alpha(Mon, Mar 11)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 6.88 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.00 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.00 |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
IGI Laboratories, Inc. develops, manufactures, and markets topical formulations in the United States. The company sells its generic topical pharmaceutical products under the IGI label.
View More